Canopy Growth stock tumbles after announcing $200 million share sale plan
Director Joseph S. Konowiecki of Alignment Healthcare, Inc. (NASDAQ:ALHC) sold 25,000 shares of common stock on July 31, 2025, at a price of $16.0, for a total transaction value of $400,000. The transaction comes as ALHC shares have shown strong momentum, with InvestingPro data showing a 50% return over the past year. The company, currently valued at $2.56 billion, maintains a GOOD financial health score according to InvestingPro’s comprehensive analysis.
Following the transaction, Konowiecki directly owns 1,152,049 shares of Alignment Healthcare. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 5, 2025. InvestingPro analysis reveals the company trades at premium multiples, with additional insights available in the comprehensive Pro Research Report, which covers what really matters for informed investment decisions.
In other recent news, Alignment Healthcare reported impressive second-quarter 2025 earnings, with earnings per share (EPS) reaching $0.07, a significant improvement from the projected -$0.07. The company’s revenue also surpassed expectations, hitting $1 billion compared to the forecasted $960.51 million. This strong performance highlights the company’s robust business growth. Barclays (LON:BARC) responded to these results by upgrading Alignment Healthcare’s stock rating from Underweight to Equalweight. The firm also raised its price target for the company from $9.00 to $13.00. Barclays noted that the earnings report exceeded expectations, with revenue coming in 6% above forecasts and EBITDA $32 million higher than anticipated for core operations. Additionally, membership growth was reported to be 1% above projections. These developments reflect a positive outlook for Alignment Healthcare, as indicated by the analyst upgrade.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.